Document is current

Article History

Received: 6 November 2023

Accepted: 5 December 2023

First Online: 20 January 2024

Declarations

:

: Lizaveta Chychko, Sonja K. Schickhardt, Hyeck-Soo Son and Ingo Lieberwirth have nothing to disclose. Timur M. Yildirim reports personal fees from Alcon and Hoya and non-financial support from Johnson & Johnson. Gerd U. Auffarth reports grants, personal fees, non-financial support and consulting fees from Johnson & Johnson and Alcon, grants, personal fees and non-financial support from Carl Zeiss Meditec, Hoya, Kowa, Oculentis/Teleon, Rayner, Santen, SIFI, URSAPHARM, grants and personal fees from Biotech, Oculus, EyeYon grants from AcuFocus, Anew, Contamac, Glaukos, Physiol, RHEACELL, outside the submitted work. Ramin Khoramnia reports research grants and lecture fees from Alcon, Hoya, Physiol, Rayner, 1stQ and Johnson & Johnson, lecture fees from Kowa, Ophtec, Teleon, Santen, AcuFocus, Bausch + Lomb and travel grants from Alcon, Teleon, Johnson & Johnson, Rayner and 1stQ outside the submitted work. No funding or sponsorship was received for this study or publication of this article.

: The patient demonstrated as representative clinical case gave written informed consent to participate in this study. The collection of patient’s data was registered in the German Clinical Register (Deutsches Register Klinischer Studien) under the reference number DRKS00007837 and was approved by the local Ethics Committee of the University of Heidelberg.